Cargando…
Role of bendamustine in the treatment of chronic lymphocytic leukemia
Major advances in the management of patients with chronic lymphocytic leukemia (CLL) include an enhanced ability to make an accurate diagnosis and define clinically meaningful prognostic groups, while improving outcome through more effective therapeutic regimens and supportive care. Nevertheless, CL...
Autores principales: | Jamshed, Saad, Cheson, Bruce D |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886335/ https://www.ncbi.nlm.nih.gov/pubmed/20616893 |
Ejemplares similares
-
Oblimersen for the treatment of patients with chronic lymphocytic leukemia
por: Cheson, Bruce D
Publicado: (2007) -
Transcriptional Modulation by Idelalisib Synergizes with Bendamustine in Chronic Lymphocytic Leukemia
por: Kost, Sara E. F., et al.
Publicado: (2019) -
Bendamustine and Rituximab Treatment, Chronic Lymphocytic Leukemia, Direct Antiglobulin Test, and False Negatives
por: Sriwijitalai, Won, et al.
Publicado: (2019) -
BENDAMUSTINE: AN OLD DRUG IN THE NEW ERA FOR PATIENTS WITH NON-HODGKIN LYMPHOMAS AND CHRONIC LYMPHOCYTIC LEUKEMIA
por: Bogeljić Patekar, Martina, et al.
Publicado: (2018) -
Optimal use of bendamustine in hematologic disorders: Treatment recommendations from an international consensus panel – an update
por: Cheson, Bruce D., et al.
Publicado: (2016)